drugset
Drugs / GSK2340274A
last change Aug 2012 re-read 2 minutes ago

GSK2340274A

Vaccine

Developed for
influenza
Investigated by
GlaxoSmithKline

Trials 13 · a red edge is where a trial was stopped

today NCT01236040 · Ph 1 NCT01161160 · Ph 2 NCT01008956 · Ph 2 NCT01051661 · Ph 3 NCT01059617 · Ph 1 NCT01035749 · Ph 2 NCT00979602 · Ph 3 NCT00976820 · Ph 2 NCT00979407 · Ph 3 NCT00985088 · Ph 2 NCT01001169 · Ph 2 NCT00985673 · Ph 2 NCT00989612 · Ph 2
201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT01236040 Nov 2010 → Sep 2011 influenza GlaxoSmithKline Completed No outcome recorded
Phase 1 NCT01059617 Feb 2010 → Jan 2011 influenza GlaxoSmithKline Completed No outcome recorded
Phase 28 trials
Phase 2 NCT01161160 Jul → Aug 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT01008956 Apr → Oct 2010 influenza GlaxoSmithKline Withdrawn No outcome recorded
Phase 2 NCT01035749 Feb → Sep 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00976820 Oct 2009 → Mar 2011 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00985088 Oct → Nov 2009 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT01001169 Oct 2009 → May 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00985673 Oct → Dec 2009 influenza GlaxoSmithKline Completed No outcome recorded
Phase 2 NCT00989612 Oct 2009 → Apr 2010 influenza GlaxoSmithKline Completed No outcome recorded
Phase 33 trials
Phase 3 NCT01051661 Feb 2010 → Aug 2011 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00979602 Nov 2009 → Jan 2011 influenza GlaxoSmithKline Completed No outcome recorded
Phase 3 NCT00979407 Oct → Nov 2009 influenza GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 13 sources stand behind the page.

FieldValueCited text
Known as GSK2340274A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00985673 ↗
12

NCT01008956 ↗

NCT00976820 ↗

NCT00989612 ↗

NCT01059617 ↗

NCT00985088 ↗

NCT01001169 ↗

NCT01051661 ↗

NCT00979407 ↗

NCT00979602 ↗

NCT01161160 ↗

NCT01236040 ↗

NCT01035749 ↗
Modality Vaccine “Influenza vaccine GSK2340274A” NCT00979407 ↗
Route Intramuscular “Two intramuscular injections at Day 0 and Day 21” NCT00979407 ↗